Pancreatic cancer remains a leading global cause of death, exacerbated by aging demographics and rising risk factors like obesity and smoking. Despite its generally poor prognosis, advancements in treatment have emerged, particularly through neoadjuvant therapies, targeted therapies based on genetic testing, and immune checkpoint inhibitors. Minimally invasive surgical techniques have enhanced the safety and efficacy of surgical interventions, improving survival outcomes. A comprehensive review of these evolving treatments offers hope for better management of both localized and metastatic pancreatic cancer.
Review by Hayat U, Croce PS (…) Hanif A et 6 al. in J Clin Med